期刊文献+

72例隐源性肝炎肝穿活体组织检查病理分析 被引量:5

The Pathological Analyse of Liver Biopsy in 72 Patients with Cryptogenetic Hepatitis
下载PDF
导出
摘要 目的通过肝穿活检肝组织病理,提高对隐源性肝炎的临床诊疗水平,减少漏诊及误诊。方法对72例隐源性肝炎穿刺活检组织,经10%中性甲醛固定,快速石蜡连续切片,常规HE、Massorn染色和乙型肝炎病毒抗原免疫组织化学染色,部分病理切片进行铜染色及糖原染色。结果经病理确诊为慢性乙型肝炎19例(26.4%),非酒精性脂肪性肝炎(NASH)12例(16.7%),酒精性脂肪性肝炎(ASH)4例(5.6%),假性肝炎3例(4.2%),原发性胆汁性肝硬化(PBC)2例(2.8%),Willson’s病1例(1.4%),原因不明的31例(43.1%)。结论“隐源性肝炎”中慢性乙型肝炎、NASH所占比率较高,对不明原因的肝损害患者行肝穿活检肝组织病理检查能提高诊断率。 Objective To elevate the clinical diagnostic and therapic level, and to decrease the missed diagnosis and misdiagnosis by liver biopsy.Methods 72 patients with cryptogenetic hepatitis were performed by liver biopsy. The tissue samples were fixed in formalin, sected serial sections, and stained with HE dyeing, Massom dyeing and HBV antigens immunohistochemical dyeing, parts were stained with cupmm dyeing or staining for glycogen. Results Final diagnosis: There are 19 patients (26.4%) with chronic hepatitis B, 12 (16.7%) with NASH, 4 (5.6%) with ASH, 3 (4.2%)with false hepatitis, 2 (2.8%)with PBC, 1 (1.4%)with Willson, s desease, 31 (43.1%) with cryptogenetic hepatitis. Conclusions The ratios of chronic hepatitis B and NASH were relativly high in cryptogenetic hepatitis; It can elevate the accuracy rating of clinical diagnosis for patients with cryptogenetic hepatitis by liver biopsy.
作者 钱云松
出处 《医学研究杂志》 2006年第6期50-51,共2页 Journal of Medical Research
关键词 肝穿 活体组织 病理 隐源性肝炎 Liver puncture Liver biopsy Cryptogenetic hepatitis
  • 相关文献

参考文献4

二级参考文献31

  • 1[8]Dickson RC, Everhart JE, Lake .JR, et al. Transmission of hepatitis B by transplantation of livers form donors positive for antibody to hepatitis B core antigen. Gastroenterology, 1997,113(5): 1668-1674.
  • 2[9]Koyanagi T, Nakamuta M, Sakai H, et al. Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu 129 to Asp and Gly 145 to Ala in the surface antigen gene. Med Sci Monit,2000,6(6): 1165-1169.
  • 3[10]Hou J, Wang Z, Cheng J, et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology, 2001,34 (5): 1027-1034.
  • 4[11]Takaguchi K, Satou A, Ando M, et al. Detection of hepatitis B virus DNA in the liver andserum of patients with hepatitis B surface antigen and hepatitis C virus antibody negative chronic liver disease. Hepatol Res, 2002,22 (2):139-144.
  • 5[12]Conjeevaram HS,Lok AS.Occult hepatitis B virus infection:A hidden menace? Hepatology,2001,34( 1 ) ;204-206.
  • 6[13]Mason A, Xu L, Guo L, et al. Molecular basis for persistent hepatitis B virus infection in the live after clearance of serum surface antigen. Hepatology, 1998,27(6): 1736-1742.
  • 7[14]Marusawa H, Uemoto S, Hijikata M, et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology,2000,31 (2) :488-495.
  • 8[15]Sato S, Ohhashi W, Ihara H, et al. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay.Transfusion, 2001,41(9) :1107-1113.
  • 9[16]Chu CM,Yeh CT,Liaw YF,et al. Low-level viremia and intracellullar expresion of HBsAg in HBsAg carriers with concurrent hepatitis C virus C. J Clin Microbiol, 1998,36 (7): 2084-2086.
  • 10[17]Tsuji H, Shimomura H Fujio K. et al. Relationship of serum markers of hepatitis B and C virus replication in coinfected patientsl. Acta Med Okayama, 1998,52(2): 113-118.

共引文献14034

同被引文献32

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部